We decided to focus our investigation on SK-N-Be2c neuroblastoma cells, since this cell line accumulates MYCN amplification, TP53 mutation, and chemoresistance, but also has a high sensitivity to Mps1 inhibition. The gene discussed is MYCN; the disease is neuroblastoma.